Markets
markets
Luke Kawa

CoreWeave rallies as Jane Street reveals 5.4% stake

Before all that recent selling in CoreWeave shares due to the IPO lockup period expiring, there was also a big buyer.

Quantitative trading and market-making firm Jane Street accumulated a passive position of nearly 20 million shares, or 5.4% of the company, as of August 13, according to a 13G filing. As of that date, that stake was worth about $2.35 billion, or about $1.8 billion as of Wednesday’s close. Over half that reported position is in Jane Street’s options division.

Shares of CoreWeave are up about 3% as of 7:50 a.m. ET amid this news.

It should be stressed that Jane Street is a quantitative trading firm and liquidity provider, and that it amassed a large position CoreWeave shares ahead of what was sure to be a surge in trading volume. This stake is not necessarily an obvious signal of optimism regarding the near-term prospects for CoreWeave stock, but potentially more so the result of Jane Street identifying an attractive trading opportunity. But it could be both! Or just one.

That being said, if you are looking for a positive catalyst for CoreWeave, I would humbly suggest that the end of the initial rush of post-lockup selling is a much better one than the idea that the filing implies Jane Street thinks the shares are going to moon.

More Markets

See all Markets
markets

IREN drops on convertible debt offering

Shares of crypto miner and AI compute provider IREN dropped after the Australia-based, US-listed company said late Tuesday that it would sell $875 million in convertible senior debt.

The announcement came late in the trading day and caused a sell-off in the aftermarket session that continued into Wednesday trading.

The offering makes sense; the company can probably get some fairly cheap capital after its shares doubled over the last month.

But it exposes shareholders to some dilution risk if buyers of the hybrid securities do convert them into equity, which explains the market reaction.

The offering makes sense; the company can probably get some fairly cheap capital after its shares doubled over the last month.

But it exposes shareholders to some dilution risk if buyers of the hybrid securities do convert them into equity, which explains the market reaction.

markets

Tempus AI shares surge to all-time high

Shares of Tempus AI jumped over 7% Wednesday to reach an all-time high of $99.90. Shares of the AI medical diagnostics company are up over 191% for the year so far.

The company has recently announced a flurry of FDA clearances for its technologies. Most recently, on September 22, Tempus AI was granted FDA clearance for its Tempus xR IVD device, which is used to tailor cancer therapies.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.